JP5440564B2 - Method for detecting crystal defects - Google Patents
Method for detecting crystal defects Download PDFInfo
- Publication number
- JP5440564B2 JP5440564B2 JP2011155910A JP2011155910A JP5440564B2 JP 5440564 B2 JP5440564 B2 JP 5440564B2 JP 2011155910 A JP2011155910 A JP 2011155910A JP 2011155910 A JP2011155910 A JP 2011155910A JP 5440564 B2 JP5440564 B2 JP 5440564B2
- Authority
- JP
- Japan
- Prior art keywords
- heat treatment
- oxygen
- crystal
- defect
- wafer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
- H10P74/00—Testing or measuring during manufacture or treatment of wafers, substrates or devices
- H10P74/20—Testing or measuring during manufacture or treatment of wafers, substrates or devices characterised by the properties tested or measured, e.g. structural or electrical properties
- H10P74/203—Structural properties, e.g. testing or measuring thicknesses, line widths, warpage, bond strengths or physical defects
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
- H10P74/00—Testing or measuring during manufacture or treatment of wafers, substrates or devices
- H10P74/23—Testing or measuring during manufacture or treatment of wafers, substrates or devices characterised by multiple measurements, corrections, marking or sorting processes
- H10P74/235—Testing or measuring during manufacture or treatment of wafers, substrates or devices characterised by multiple measurements, corrections, marking or sorting processes comprising optical enhancement of defects or not-directly-visible states
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Testing Or Measuring Of Semiconductors Or The Like (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Description
本発明は、シリコン単結晶ウェーハの結晶欠陥を検出する方法に関し、特には、結晶欠陥を顕在化させて検出する方法に関する。 The present invention relates to a method for detecting a crystal defect in a silicon single crystal wafer, and more particularly to a method for detecting a crystal defect by revealing it.
シリコン単結晶は、酸素濃度を低下させると、結晶欠陥サイズが小さくなる傾向がある。例えば、初期格子間酸素濃度が8ppma以下、特には5ppma以下のように低酸素濃度のシリコン単結晶から切り出されたシリコン単結晶ウェーハのような場合、BMD(Bulk Micro Defect)、COP(Crystal Originated Particle)、「空洞」などの微小な結晶欠陥の検出が難しいため、切り出されたシリコン単結晶ウェーハが無欠陥領域かどうかの欠陥領域の判定が極めて困難となっている。 Silicon single crystals tend to reduce the crystal defect size when the oxygen concentration is lowered. For example, in the case of a silicon single crystal wafer cut from a silicon single crystal having a low oxygen concentration such that the initial interstitial oxygen concentration is 8 ppma or less, particularly 5 ppma or less, BMD (Bulk Micro Defect), COP (Crystal Originated Particle) ), Since it is difficult to detect minute crystal defects such as “cavities”, it is extremely difficult to determine whether or not a cut silicon single crystal wafer is a defect-free region.
サイズが微小なために検出が困難な結晶欠陥については、該結晶欠陥を顕在化する処理を行ってから検出を行う方法が知られている。 For crystal defects that are difficult to detect because of their small size, a method is known in which detection is performed after performing a process for revealing the crystal defects.
例えば、特許文献1には、シリコンウエーハの評価方法であって、特定の測定装置により検出可能な酸素析出物の下限サイズより小さな酸素析出物を含有するシリコンウエーハに、新たな酸素析出物を発生させることなく酸素析出物を成長させる熱処理を加えて、前記下限サイズより小さな酸素析出物のすべてを前記特定の測定装置により検出可能なサイズに成長させた後に、前記シリコンウエーハ中の酸素析出物密度を前記特定の測定装置により測定することを特徴とするシリコンウエーハの評価方法が記載されている。 For example, Patent Document 1 discloses a silicon wafer evaluation method in which new oxygen precipitates are generated on a silicon wafer containing oxygen precipitates smaller than the lower limit size of oxygen precipitates detectable by a specific measuring device. The oxygen precipitate density in the silicon wafer is increased after all the oxygen precipitates smaller than the lower limit size are grown to a size that can be detected by the specific measuring device. A method for evaluating a silicon wafer is described in which the above-mentioned measurement is performed by the specific measuring device.
また、特許文献2には、バルクシリコン基板中の結晶欠陥を予防的に顕在化する方法であって、500℃〜1300℃の範囲内の温度において非還元性雰囲気中で実施される、「顕在化熱処理」と称する熱処理にかける方法が記載されている。この「顕在化熱処理」は具体的には、酸素、アルゴンまたは窒素あるいはそれら2つの混合物の雰囲気下で行われる。 Patent Document 2 discloses a method for proactively revealing crystal defects in a bulk silicon substrate, which is performed in a non-reducing atmosphere at a temperature in the range of 500 ° C. to 1300 ° C. A method of subjecting to a heat treatment referred to as "chemical heat treatment" is described. Specifically, this “sensible heat treatment” is performed in an atmosphere of oxygen, argon, nitrogen, or a mixture of the two.
上記のように、低酸素濃度のシリコン単結晶ウェーハ(低酸素ウェーハ)の場合、BMD、COP、及び「空洞」などの微小な結晶欠陥の検出が困難になってきているという問題があった。特に、窒素がドープされた低酸素ウェーハでは、より欠陥サイズが小さくなるので、特に「空洞」のような25nm以下の微小欠陥は、現在の欠陥評価の方法では検出することができなかった。 As described above, in the case of a silicon single crystal wafer having a low oxygen concentration (low oxygen wafer), there is a problem that it is difficult to detect minute crystal defects such as BMD, COP, and “cavity”. In particular, since the defect size becomes smaller in a low-oxygen wafer doped with nitrogen, a minute defect of 25 nm or less such as a “cavity” cannot be detected by the current defect evaluation method.
本発明は、このような問題点に鑑みてなされたもので、窒素がドープされた低酸素濃度のシリコン単結晶ウェーハに存在する、特にサイズが小さい結晶欠陥を検出することのできる結晶欠陥の検出方法を提供することを目的とする。 The present invention has been made in view of such problems, and it is possible to detect a crystal defect that can detect a crystal defect that is present in a low oxygen concentration silicon single crystal wafer doped with nitrogen and that is particularly small in size. It aims to provide a method.
本発明は、上記課題を解決するためになされたもので、窒素をドープした初期酸素濃度8ppma(JEIDA)以下のシリコン単結晶ウェーハに存在する結晶欠陥の検出方法であって、前記シリコン単結晶ウェーハに酸素雰囲気下にて熱処理を行うことにより、前記結晶欠陥内に酸素を注入し、欠陥サイズが25nm以下の結晶欠陥を顕在化して検出可能にする工程と、前記熱処理後のシリコン単結晶ウェーハの結晶欠陥を検出する工程とを含み、前記熱処理時における、前記シリコン単結晶ウェーハの酸素固溶度と初期酸素濃度の比率を、α=酸素固溶度/初期酸素濃度としたとき、αを1以上3以下の範囲になるように前記熱処理における熱処理温度を設定することを特徴とする結晶欠陥の検出方法を提供する。 The present invention has been made to solve the above-mentioned problems, and is a method for detecting crystal defects existing in a silicon single crystal wafer having an initial oxygen concentration of 8 ppma (JEIDA) or less doped with nitrogen, the silicon single crystal wafer being Performing a heat treatment in an oxygen atmosphere to inject oxygen into the crystal defects, revealing crystal defects having a defect size of 25 nm or less, and enabling detection of the crystal defects after the heat treatment. A ratio of oxygen solid solubility and initial oxygen concentration of the silicon single crystal wafer at the time of the heat treatment is α = oxygen solid solubility / initial oxygen concentration. There is provided a crystal defect detection method, characterized in that the heat treatment temperature in the heat treatment is set so as to be in the range of 3 or less.
このようにして、αが1以上3以下の範囲になるように熱処理温度を設定した熱処理により、欠陥サイズが25nm以下の結晶欠陥の大多数を顕在化して検出可能にすることができる。この顕在化した結晶欠陥を検出することにより、欠陥サイズが25nm以下だった結晶欠陥も検出することができる。 In this way, by heat treatment in which the heat treatment temperature is set so that α is in the range of 1 to 3, the majority of crystal defects having a defect size of 25 nm or less can be made manifest and detectable. By detecting this actual crystal defect, the crystal defect whose defect size is 25 nm or less can also be detected.
この場合、前記熱処理温度を900℃〜1200℃とし、前記熱処理を行う時間を10〜60分とすることが好ましい。 In this case, it is preferable that the heat treatment temperature is 900 ° C. to 1200 ° C., and the heat treatment time is 10 to 60 minutes.
このような熱処理温度及び熱処理時間であれば、より確実にシリコン単結晶ウェーハの結晶欠陥を顕在化することができる。 With such a heat treatment temperature and heat treatment time, crystal defects of the silicon single crystal wafer can be manifested more reliably.
また、本発明は、前記シリコン単結晶ウェーハの窒素ドープ濃度を、1×1013〜1×1015atoms/cm3とする場合に好適である。 Further, the present invention is suitable when the nitrogen dope concentration of the silicon single crystal wafer is 1 × 10 13 to 1 × 10 15 atoms / cm 3 .
このような窒素ドープ濃度のシリコン単結晶ウェーハでは、特に結晶欠陥のサイズが小さいので、本発明により結晶欠陥を顕在化して検出する方法が特に有効である。 In such a nitrogen-doped silicon single crystal wafer, since the size of the crystal defect is particularly small, the method of revealing and detecting the crystal defect according to the present invention is particularly effective.
また、本発明は、前記結晶欠陥の検出を、光散乱方式のパーティクルカウンタによる検出、コンフォーカル光学系のレーザー顕微鏡による検出、及び、RIE法による検出のいずれかにより行うことできる。 In the present invention, the crystal defect can be detected by any one of detection by a light scattering type particle counter, detection by a laser microscope of a confocal optical system, and detection by an RIE method.
これらのような方法により、本発明によって顕在化された結晶欠陥を検出することができる。 By such a method, the crystal defect manifested by the present invention can be detected.
本発明に係る結晶欠陥の検出方法であれば、特に結晶欠陥の欠陥サイズが小さい、窒素がドープされた低酸素ウェーハであっても、欠陥サイズの小さい結晶欠陥を顕在化して検出可能とすることができる。この顕在化した結晶欠陥を検出することにより、欠陥サイズが25nm以下だった欠陥も検出することができる。その結果、窒素がドープされた低酸素ウェーハの結晶欠陥をより正確に評価できる。 With the crystal defect detection method according to the present invention, crystal defects with a small defect size should be made obvious and detectable even in a low-oxygen wafer doped with nitrogen, particularly with a small defect size. Can do. By detecting the actual crystal defects, defects having a defect size of 25 nm or less can also be detected. As a result, the crystal defects of the low oxygen wafer doped with nitrogen can be more accurately evaluated.
以下、本発明を詳細に説明するが、本発明はこれらに限定されるものではない。 Hereinafter, the present invention will be described in detail, but the present invention is not limited thereto.
まず、本発明において結晶欠陥を検出可能にするメカニズムについて説明する。 First, a mechanism that enables detection of crystal defects in the present invention will be described.
上記のように、低酸素濃度のシリコン単結晶ウェーハ(低酸素ウェーハ)の場合、BMD、COP、及び「空洞」などの微小な結晶欠陥の検出が困難になってきているという問題があった。特に、窒素がドープされた低酸素ウェーハでは、より欠陥サイズが小さくなるので、特に「空洞」のような25nm以下の微小欠陥は、現在の欠陥評価の方法では検出することができなかった。 As described above, in the case of a silicon single crystal wafer having a low oxygen concentration (low oxygen wafer), there is a problem that it is difficult to detect minute crystal defects such as BMD, COP, and “cavity”. In particular, since the defect size becomes smaller in a low-oxygen wafer doped with nitrogen, a minute defect of 25 nm or less such as a “cavity” cannot be detected by the current defect evaluation method.
微小なBMD、COPの欠陥検出用の高感度評価方法としては、反応性イオンエッチングによるRIE(Reactive Ion Etching)法や、レーザーの散乱によりウェーハ断面を検査する方法(例えば、レイテックス社製の結晶欠陥検査装置MO441を用いる方法)などがある。 High sensitivity evaluation methods for detecting defects in minute BMDs and COPs include RIE (Reactive Ion Etching) by reactive ion etching, and methods for inspecting a wafer cross section by laser scattering (for example, crystals manufactured by Raytex) And the like using a defect inspection apparatus MO441.
RIE法は検出下限値が約10nmで、微小BMDの検出に有効であるが、内面酸化膜が薄いCOPに対しては検出下限値より大きいサイズであっても検出されないという問題があった。 The RIE method has a detection lower limit of about 10 nm and is effective for detection of minute BMDs, but has a problem that a COP with a thin inner oxide film is not detected even if the size is larger than the detection lower limit.
一方、ウェーハ断面に対するレーザー散乱法の場合は、ウェーハ表層の情報を得ることができず、バルクの欠陥評価のみに適用可能であった。また、評価されるエリアが狭く、結晶欠陥の面内分布の評価ができないという問題があった。 On the other hand, in the case of the laser scattering method for the wafer cross section, information on the wafer surface layer could not be obtained, and it was applicable only to bulk defect evaluation. Further, there is a problem that the area to be evaluated is narrow and the in-plane distribution of crystal defects cannot be evaluated.
そこで、本発明では、まずシリコン単結晶ウェーハに酸素雰囲気下にて熱処理を行うことにより微小な結晶欠陥内に酸素を注入して微小欠陥内に内面酸化膜を形成するとともに、欠陥サイズを大きくし、顕在化させる。次に、このように熱処理後の顕在化した結晶欠陥を所定の方法により検出する。 Therefore, in the present invention, first, a silicon single crystal wafer is heat-treated in an oxygen atmosphere to inject oxygen into minute crystal defects to form an inner surface oxide film in the minute defects, and to increase the defect size. , Make it manifest. Next, the crystal defects that have become apparent after the heat treatment are detected by a predetermined method.
結晶欠陥を顕在化させるための熱処理における酸素の注入は、熱処理温度におけるシリコン単結晶ウェーハの酸素固溶度が、ウェーハの初期酸素濃度以上(酸素固溶度≧初期酸素濃度)であることが絶対条件である。すなわち、ウェーハの酸素の固溶度が低いと結晶欠陥中に酸素を注入することができない。 Oxygen injection in the heat treatment for revealing crystal defects must be such that the oxygen solid solubility of the silicon single crystal wafer at the heat treatment temperature is equal to or higher than the initial oxygen concentration of the wafer (oxygen solid solubility ≧ initial oxygen concentration). It is a condition. That is, if the solid solubility of oxygen in the wafer is low, oxygen cannot be injected into the crystal defects.
熱処理温度が高くなるにつれて、ウェーハの酸素固溶度は高くなり、ウェーハ中に酸素を注入しやすくなる。 As the heat treatment temperature increases, the oxygen solid solubility of the wafer increases and oxygen is easily injected into the wafer.
しかし、熱処理温度が高すぎると酸素をウェーハ中に注入しても、昇温段階に結晶欠陥が外方拡散したり、サイズが小さい(臨界サイズより遥かに小さい場合)結晶欠陥が消滅して、結晶欠陥の評価を適正に行うことができない。 However, if the heat treatment temperature is too high, even if oxygen is injected into the wafer, the crystal defects diffuse out in the temperature rising stage, or the crystal defects disappear when the size is small (if much smaller than the critical size) Crystal defects cannot be properly evaluated.
逆に、熱処理温度が低すぎると酸素固溶度とウェーハ中の酸素濃度の差が小さくなって、結晶欠陥中に酸素注入が困難になって結晶欠陥の顕在化ができない。 On the other hand, if the heat treatment temperature is too low, the difference between the oxygen solid solubility and the oxygen concentration in the wafer becomes small, and it becomes difficult to inject oxygen into the crystal defects, making it impossible to reveal the crystal defects.
その結果、ウェーハ中の酸素濃度に対して、適切な熱処理温度、つまりは適切な酸素の固溶度にする必要があることに想到し、酸素固溶度/初期酸素濃度と結晶欠陥の挙動の関係について調査した。 As a result, it is thought that it is necessary to set an appropriate heat treatment temperature, that is, an appropriate oxygen solid solubility with respect to the oxygen concentration in the wafer, and the oxygen solid solubility / initial oxygen concentration and the behavior of crystal defects The relationship was investigated.
ここでは、(1)結晶欠陥の顕在化ができるモデル、(2)外方拡散モデル、(3)内方拡散(欠陥消滅)モデル、(4)結晶欠陥の顕在化が十分ではないモデル、という4つのモデルがあるので、図1〜4を参照しながらこれらのモデルについて説明する。 Here, (1) a model that can reveal crystal defects, (2) an outward diffusion model, (3) an inward diffusion (defect annihilation) model, and (4) a model that does not reveal crystal defects sufficiently. Since there are four models, these models will be described with reference to FIGS.
(1)結晶欠陥の顕在化ができるモデル
図1を参照して、結晶欠陥の顕在化ができるモデルを説明する。このモデルは、後述のように、1≦α(=酸素固溶度/初期酸素濃度)≦3のときに成り立つ。
(1) Model capable of revealing crystal defects With reference to FIG. 1, a model capable of revealing crystal defects will be described. As will be described later, this model is established when 1 ≦ α (= oxygen solid solubility / initial oxygen concentration) ≦ 3.
図1(a)は熱処理前の段階のシリコン単結晶ウェーハの結晶状態を示している。COP、BMD、空洞等の結晶欠陥が存在しており、COPとしては、特に小さいサイズのものや、酸化膜の薄いものなども存在している。 FIG. 1A shows the crystalline state of the silicon single crystal wafer before the heat treatment. There are crystal defects such as COP, BMD, and cavities, and as COPs, there are particularly small-sized and thin oxide films.
このシリコン単結晶ウェーハに対し熱処理を行う際(熱処理段階)の結晶欠陥の変化を図1(b−1)の昇温段階と図1(b−2)酸素拡散段階にわけて説明する。昇温段階では、雰囲気中の酸素によりウェーハ表面に酸化膜が形成され、ウェーハ内に格子間シリコンが発生する。この格子間シリコンの導入により、COPの酸化膜が薄くなったり、空洞など縮小する傾向があるが、消滅までには至らない。次の酸素拡散段階では、雰囲気中の酸素の注入により、COPはその内面酸化膜が厚くなって、BMDはそのサイズが拡大し、空洞はその内面に酸化膜が形成される。これによって、各結晶欠陥が顕在化される。 Changes in crystal defects during the heat treatment (heat treatment stage) of the silicon single crystal wafer will be described by dividing into a temperature rising stage in FIG. 1 (b-1) and an oxygen diffusion stage in FIG. 1 (b-2). In the temperature raising stage, an oxide film is formed on the wafer surface by oxygen in the atmosphere, and interstitial silicon is generated in the wafer. The introduction of interstitial silicon tends to make the COP oxide film thinner or to reduce cavities, but it does not disappear. In the next oxygen diffusion stage, the inner surface oxide film of COP becomes thicker due to the implantation of oxygen in the atmosphere, the size of BMD increases, and the oxide film is formed on the inner surface of the cavity. Thereby, each crystal defect becomes obvious.
このように酸素雰囲気下での熱処理によって結晶欠陥が顕在化し、図1(c)に示したように、顕在化した結晶欠陥の検出が可能になる。 As described above, the crystal defects are manifested by the heat treatment in the oxygen atmosphere, and the manifested crystal defects can be detected as shown in FIG.
なお、図1中の点線は、熱処理前段階と比較した酸素濃度の変化を図中に表したものである。結晶欠陥が顕在化する領域は酸素注入された領域(酸素濃度を表す点線により酸素濃度が熱処理前よりも増加していることが示されている領域)である。 In addition, the dotted line in FIG. 1 represents the change of the oxygen concentration compared with the stage before heat processing in the figure. A region where crystal defects become apparent is a region where oxygen is implanted (a region where the oxygen concentration is shown to be higher than that before heat treatment by a dotted line representing the oxygen concentration).
(2)外方拡散モデル
図2を参照して、酸素が外方拡散するモデルを説明する。このモデルは、後述のように、酸素固溶度/初期酸素濃度=α<1のときに成り立つ。
(2) Outward diffusion model A model in which oxygen diffuses outward will be described with reference to FIG. As will be described later, this model is established when oxygen solid solubility / initial oxygen concentration = α <1.
図2(a)は図1(a)と同様に、熱処理前段階の結晶状態を示している。 FIG. 2 (a) shows the crystal state before the heat treatment, as in FIG. 1 (a).
図2(b)は熱処理段階を示している。シリコン単結晶ウェーハの酸素濃度がウェーハの酸素固溶度より高い場合、表面に酸化膜が形成され、格子間シリコンが発生し、また、ウェーハ表層に存在していた酸素の外方拡散が起こる。これにより、以下のような現象が生じる。まず、酸素の外方拡散により、COP内面酸化膜が溶け、空洞になる。また、格子間シリコンの注入により、空洞が埋められ、小さくなる。また、小さい空洞が埋められ、結晶欠陥が消滅する。そのため、ウェーハ表層部の欠陥状態及び欠陥数が変わるため、そのままでは正確な欠陥評価ができない。 FIG. 2B shows the heat treatment stage. When the oxygen concentration of the silicon single crystal wafer is higher than the oxygen solid solubility of the wafer, an oxide film is formed on the surface, interstitial silicon is generated, and outdiffusion of oxygen existing on the wafer surface layer occurs. As a result, the following phenomenon occurs. First, due to the outward diffusion of oxygen, the COP inner surface oxide film is melted and becomes a cavity. Moreover, the cavity is filled and becomes smaller by the implantation of interstitial silicon. In addition, small cavities are filled and crystal defects disappear. For this reason, since the defect state and the number of defects on the wafer surface layer portion are changed, accurate defect evaluation cannot be performed as it is.
なお、図2中の点線は、熱処理前段階と比較した酸素濃度の変化を図中に表したものである。図中に示したように、表層部分の酸素が外方拡散して低下している。 In addition, the dotted line in FIG. 2 represents the change of the oxygen concentration compared with the stage before heat processing in the figure. As shown in the figure, oxygen in the surface layer portion is diffused outwardly and decreased.
(3)内方拡散(欠陥消滅)モデル
図3を参照して、酸素が内方拡散し、結晶欠陥が消滅するモデルを説明する。このモデルは、後述のように、酸素固溶度/初期酸素濃度=α>3のときに成り立つ。
(3) Inward diffusion (defect annihilation) model With reference to FIG. 3, a model in which oxygen diffuses inward and crystal defects disappear will be described. As will be described later, this model is established when oxygen solid solubility / initial oxygen concentration = α> 3.
図3(a)は図1(a)及び図2(a)と同様に、熱処理前段階の結晶状態を示している。 FIG. 3 (a) shows the crystal state before the heat treatment, as in FIGS. 1 (a) and 2 (a).
このシリコン単結晶ウェーハに対し熱処理を行う際(熱処理段階)の結晶欠陥の変化を図3(b−1)の昇温段階と図3(b−2)酸素拡散段階にわけて説明する。ウェーハに欠陥サイズが小さい、空洞が存在する場合、(b−1)の昇温段階に臨界サイズより小さい結晶欠陥が消滅する。また、酸素拡散段階では、表面酸化膜形成が促進され、格子間シリコンの注入が優勢となるため、空洞を埋めて空洞欠陥が消滅する。 Changes in crystal defects during the heat treatment (heat treatment stage) of the silicon single crystal wafer will be described by dividing into a temperature rising stage in FIG. 3 (b-1) and an oxygen diffusion stage in FIG. 3 (b-2). When the defect size is small and the cavity exists in the wafer, crystal defects smaller than the critical size disappear at the temperature rising stage of (b-1). In the oxygen diffusion stage, the formation of the surface oxide film is promoted, and the implantation of interstitial silicon becomes dominant, so that the cavity is filled and the cavity defect disappears.
また、ウェーハ表層では、臨界サイズ以上の結晶欠陥が昇温段階に少し溶ける。但し、酸素の内方拡散に伴い結晶欠陥が成長する(COP内面酸化膜が厚くなり、空洞内面に酸化膜が形成され、BMDも成長する)。 In addition, on the wafer surface layer, crystal defects larger than the critical size are slightly dissolved in the temperature rising stage. However, crystal defects grow with the inward diffusion of oxygen (the COP inner surface oxide film becomes thicker, an oxide film is formed on the inner surface of the cavity, and BMD also grows).
図3中の点線は、熱処理前段階と比較した酸素濃度の変化を図中に表したものである。結晶欠陥が顕在化する領域は酸素注入された領域(酸素濃度を表す点線により酸素濃度が熱処理前よりも増加していることが示されている領域)である。 The dotted line in FIG. 3 represents the change in oxygen concentration compared to the pre-heat treatment stage. A region where crystal defects become apparent is a region where oxygen is implanted (a region where the oxygen concentration is shown to be higher than that before heat treatment by a dotted line representing the oxygen concentration).
このモデルでは、上記のように表層欠陥が消滅することがあるので、熱処理後に光散乱方式のパーティクルカウンタや、コンフォーカル光学系のレーザー顕微鏡を用いて表層欠陥の評価をする際に正確な評価ができない。 In this model, surface layer defects may disappear as described above, so accurate evaluation is possible when evaluating surface layer defects using a light scattering type particle counter or a confocal optical laser microscope after heat treatment. Can not.
(4)結晶欠陥の顕在化が十分ではないモデル
図4を参照して、熱処理温度が低すぎる場合に結晶欠陥の顕在化が十分にならないモデルを説明する。図4(a)は図1(a)、図2(a)及び図3(a)と同様に、熱処理前段階の結晶状態を示している。
(4) Model in which crystal defects are not sufficiently manifested With reference to FIG. 4, a model in which crystal defects are not sufficiently manifested when the heat treatment temperature is too low will be described. FIG. 4A shows the crystal state before the heat treatment, as in FIGS. 1A, 2A, and 3A.
図4(b)は熱処理段階を示している。熱処理温度が低すぎる場合、表面酸化膜成長速度が遅く、発生する格子間シリコンが少ないため、COP、BMD、空洞はサイズが小さくても消滅しない。また、酸素拡散係数が小さいため、ウェーハ表層に僅かな酸素注入しかしない。結局、熱処理後も元のウェーハ状態に影響せず、結晶欠陥の顕在化に効果がない。すなわち、図4(c)の測定段階のウェーハは図4(a)の初期ウェーハと比べて変化がほとんどないものである。 FIG. 4B shows the heat treatment stage. When the heat treatment temperature is too low, the growth rate of the surface oxide film is slow and the generated interstitial silicon is small, so that COP, BMD, and cavities do not disappear even if the size is small. In addition, since the oxygen diffusion coefficient is small, only a small amount of oxygen is injected into the wafer surface layer. As a result, the original wafer state is not affected even after the heat treatment, and the crystal defects are not effective. That is, the wafer in the measurement stage of FIG. 4 (c) has little change compared to the initial wafer of FIG. 4 (a).
図4中の点線は、熱処理前段階と比較した酸素濃度の変化を図中に表したものである。 The dotted line in FIG. 4 represents the change in oxygen concentration compared to the pre-heat treatment stage.
(実験)
結晶欠陥の顕在化のために最適なα=酸素固溶度/初期酸素濃度の値(上記モデルのうち、(1)結晶欠陥の顕在化ができるモデルに当てはまる値)を求めるため、以下の実験を行った。
(Experiment)
In order to obtain the optimum value of α = oxygen solid solubility / initial oxygen concentration for the manifestation of crystal defects (among the above models, (1) a value applicable to a model capable of revealing crystal defects), the following experiment Went.
窒素ドープしたウェーハの熱処理温度と酸素固溶度との関係及び種々の基板酸素濃度(1、3、5、8、10ppma(JEIDA))にそれぞれ種々の熱処理条件(温度:900、1000、1100、1200、1250℃、時間:30分固定、酸素雰囲気)で、コンフォーカル光学系のレーザー顕微鏡(レーザーテック社製MAGICS)を用いて評価することにより、結晶欠陥検出の有無を判断し、さらに上記4つのモデルのいずれに該当するか推定した。 The relationship between the heat treatment temperature and oxygen solid solubility of the nitrogen-doped wafer and the various substrate oxygen concentrations (1, 3, 5, 8, 10 ppma (JEIDA)) are various heat treatment conditions (temperature: 900, 1000, 1100, At 1200, 1250 ° C., time: 30 minutes, oxygen atmosphere), by using a laser microscope with a confocal optical system (MAGICS, manufactured by Lasertec Corporation), the presence or absence of crystal defect detection is determined. We estimated which model was applicable.
上記実験から、欠陥を顕在化することのできるα=酸素固溶度/初期酸素濃度の関係を導き出した。結果を以下の表1に示す。表1中において、記号[○]は熱処理前段階に比較して結晶欠陥が増加した場合を示しており、記号[×]は熱処理前段階に比較して結晶欠陥が減少又は消滅した場合を示している。また、α<1の場合は(2)外方拡散モデルに該当することが推定され、α>3の場合は(3)内方拡散(欠陥消滅)モデルに該当することが推定される。なお、(4)結晶欠陥の顕在化が十分ではないモデルは、熱処理温度がこの例よりもかなり低い温度にて現れると推定される。 From the above experiment, the relationship of α = oxygen solid solubility / initial oxygen concentration capable of revealing defects was derived. The results are shown in Table 1 below. In Table 1, the symbol [◯] indicates the case where the crystal defects are increased compared to the pre-heat treatment stage, and the symbol [×] indicates the case where the crystal defects are reduced or eliminated compared to the pre-heat treatment stage. ing. Further, when α <1, it is estimated that (2) it corresponds to the outward diffusion model, and when α> 3, it is estimated that it corresponds to (3) the inward diffusion (defect annihilation) model. In addition, it is estimated that (4) the model in which the crystal defects are not sufficiently manifested appears at a heat treatment temperature much lower than this example.
その結果、α=酸素固溶度/初期酸素濃度としたとき、αを1〜3の範囲になるように熱処理条件を選択すれば、窒素ドープした低酸素濃度のシリコン単結晶ウェーハであっても、適正な欠陥評価が可能であることがわかった。 As a result, when α = oxygen solid solubility / initial oxygen concentration, if the heat treatment conditions are selected so that α is in the range of 1 to 3, even if it is a nitrogen-doped low oxygen concentration silicon single crystal wafer It was found that proper defect evaluation is possible.
以上の見地から、本発明では、窒素をドープした初期酸素濃度8ppma(JEIDA)以下のシリコン単結晶ウェーハに存在する結晶欠陥を顕在化するために以下のように酸素雰囲気下にて熱処理を行う。すなわち、熱処理時における、シリコン単結晶ウェーハの酸素固溶度と初期酸素濃度の比率を、α=酸素固溶度/初期酸素濃度としたとき、αを1以上3以下の範囲になるように熱処理における熱処理温度を設定して、シリコン単結晶ウェーハに酸素雰囲気下にて熱処理を行うことにより、結晶欠陥内に酸素を注入し、欠陥サイズが25nm以下の結晶欠陥を顕在化して検出可能にする。このことにより、欠陥サイズが25nm以下の結晶欠陥の大多数を顕在化して検出可能にすることができる。この顕在化した結晶欠陥を検出することにより、欠陥サイズが25nm以下だった結晶欠陥も検出することができる。 From the above viewpoint, in the present invention, heat treatment is performed in an oxygen atmosphere as follows in order to reveal crystal defects present in a silicon single crystal wafer having an initial oxygen concentration of 8 ppma (JEIDA) or less doped with nitrogen. That is, when the ratio of the oxygen solid solubility of the silicon single crystal wafer and the initial oxygen concentration during the heat treatment is α = oxygen solid solubility / initial oxygen concentration, the heat treatment is performed so that α is in the range of 1 to 3. By setting the heat treatment temperature in and performing heat treatment on the silicon single crystal wafer in an oxygen atmosphere, oxygen is implanted into the crystal defects, and crystal defects having a defect size of 25 nm or less are made obvious and detectable. As a result, the majority of crystal defects having a defect size of 25 nm or less can be manifested and detected. By detecting this actual crystal defect, the crystal defect whose defect size is 25 nm or less can also be detected.
結晶欠陥の顕在化のための熱処理条件を、温度を900℃〜1200℃とし、時間を10〜60分とすることによって、適度な酸素固溶度となり、結晶欠陥内に酸素を注入することができるので、より確実にシリコン単結晶ウェーハの結晶欠陥を顕在化することができる。 By setting the temperature to 900 ° C. to 1200 ° C. and the time to 10 to 60 minutes as the heat treatment conditions for revealing crystal defects, an appropriate oxygen solid solubility can be obtained and oxygen can be injected into the crystal defects. As a result, the crystal defects of the silicon single crystal wafer can be manifested more reliably.
本発明は窒素ドープした低酸素ウェーハであれば適用できるが、窒素ドープ濃度が1×1013〜1×1015atoms/cm3である場合に特に好適である。このような窒素ドープ濃度のシリコン単結晶ウェーハでは、特に、結晶欠陥のサイズが小さいので、本発明により結晶欠陥を顕在化して検出する方法が特に有効である。 The present invention can be applied to a nitrogen-doped low oxygen wafer, but is particularly suitable when the nitrogen doping concentration is 1 × 10 13 to 1 × 10 15 atoms / cm 3 . In such a nitrogen-doped silicon single crystal wafer, since the size of the crystal defect is particularly small, the method of revealing and detecting the crystal defect according to the present invention is particularly effective.
このように顕在化した結晶欠陥を検出する方法としては、公知の方法を適宜採用することができる。特に、光散乱方式のパーティクルカウンタによる検出、コンフォーカル光学系のレーザー顕微鏡による検出、及び、RIE法による検出などを用いて検出することができる。例えば、光散乱方式のパーティクルカウンタとしては、KLAテンコール社製SP−1、コンフォーカル光学系のレーザー顕微鏡としては、レーザーテック社製MAGICS等の装置を用いることができる。 As a method of detecting the crystal defects that have become apparent in this manner, a known method can be appropriately employed. In particular, detection can be performed using detection using a light scattering particle counter, detection using a confocal optical laser microscope, detection using an RIE method, and the like. For example, an apparatus such as SP-1 manufactured by KLA Tencor can be used as a light scattering type particle counter, and MAGICS manufactured by Lasertec can be used as a laser microscope of a confocal optical system.
また、本発明により顕在化した結晶欠陥の検出のために、顕在化した結晶欠陥に含まれる酸化物をHFエッチングにより除去してもよい。ここでいう顕在化した結晶欠陥に含まれる酸化物とは、例えば、COPの内面の厚膜化された酸化膜、BMD(すなわち、酸素析出物)、空洞の内面に形成された酸化膜等である。 Further, in order to detect a crystal defect that has become apparent according to the present invention, an oxide contained in the crystal defect that has become apparent may be removed by HF etching. The oxide contained in the crystal defects manifested here is, for example, a thickened oxide film on the inner surface of the COP, BMD (that is, oxygen precipitate), an oxide film formed on the inner surface of the cavity, or the like. is there.
以下、実施例及び比較例を挙げて本発明を具体的に説明するが、これは本発明を限定するものではない。 EXAMPLES Hereinafter, although an Example and a comparative example are given and this invention is demonstrated concretely, this does not limit this invention.
(実施例1〜3、比較例1〜3)
まず、直径200mm、酸素濃度4ppma(JEIDA)、窒素濃度3×1013atoms/cm3、V領域(空孔(Vacancy)の多い領域であり、空孔とはシリコン原子の不足から発生する原子レベルの大きさの欠陥である。)のシリコン単結晶ウェーハを、6枚、同一のシリコン単結晶インゴットから切り出して準備した。
(Examples 1-3, Comparative Examples 1-3)
First, a diameter of 200 mm, an oxygen concentration of 4 ppma (JEIDA), a nitrogen concentration of 3 × 10 13 atoms / cm 3 , a V region (a region having many vacancies), and a vacancy is an atomic level generated due to a shortage of silicon atoms 6 pieces of silicon single crystal wafers were prepared by cutting out from the same silicon single crystal ingot.
次に、このうち5枚のウェーハについて、それぞれ、酸素固溶度と初期酸素濃度について、α=酸素固溶度/初期酸素濃度が0.75(比較例2)、1(実施例1)、1.5(実施例2)、3(実施例3)、3.5(比較例3)になるように熱処理条件を調整して熱処理を行った。なお、比較のため、準備した6枚のうち1枚のウェーハは、顕在化熱処理を行わなかった(比較例1)。具体的な熱処理条件は酸素雰囲気下で、温度及び時間は後に示す表2の条件で行った。 Next, of these five wafers, for oxygen solid solubility and initial oxygen concentration, α = oxygen solid solubility / initial oxygen concentration is 0.75 (Comparative Example 2), 1 (Example 1), The heat treatment was performed by adjusting the heat treatment conditions so as to be 1.5 (Example 2), 3 (Example 3), and 3.5 (Comparative Example 3). For comparison, one of the prepared six wafers was not subjected to the apparent heat treatment (Comparative Example 1). Specific heat treatment conditions were performed in an oxygen atmosphere, and the temperature and time were as shown in Table 2 below.
熱処理後の各実施例及び比較例の各ウェーハ(ただし、比較例1は熱処理をしていない)の結晶欠陥を、コンフォーカル光学系のレーザー顕微鏡(レーザーテック社製MAGICS)を用いて評価した。 Crystal defects of each of the wafers of the examples and comparative examples after heat treatment (comparative example 1 was not heat-treated) were evaluated using a laser microscope (MAGICS manufactured by Lasertec Corporation) of a confocal optical system.
図5に、表面欠陥の検出結果の画像を示す。実施例1〜3、すなわち、αがそれぞれ1、1.5、3の場合については、熱処理を行っていないウェーハ(比較例1)と比べて結晶欠陥が多く検出され、微小サイズの結晶欠陥が顕在化されたことがわかった。一方、比較例2、3、すなわち、αがそれぞれ0.75、3.5の場合については、熱処理を行っていないウェーハ(比較例1)と比べて結晶欠陥が減少し、結晶欠陥の顕在化の目的は果たせなかった。 FIG. 5 shows an image of the surface defect detection result. In Examples 1 to 3, that is, when α is 1, 1.5 and 3 respectively, more crystal defects are detected compared to the wafer not subjected to the heat treatment (Comparative Example 1), and minute crystal defects are detected. It was found that it was manifested. On the other hand, in Comparative Examples 2 and 3, that is, when α is 0.75 and 3.5, respectively, the crystal defects are reduced as compared with the wafer (Comparative Example 1) that is not subjected to the heat treatment, and the crystal defects become apparent. The purpose of could not be fulfilled.
以上の結果を以下の表2にまとめた。
なお、本発明は、上記実施形態に限定されるものではない。上記実施形態は、例示であり、本発明の特許請求の範囲に記載された技術的思想と実質的に同一な構成を有し、同様な作用効果を奏するものは、いかなるものであっても本発明の技術的範囲に包含される。 The present invention is not limited to the above embodiment. The above-described embodiment is an exemplification, and the present invention has substantially the same configuration as the technical idea described in the claims of the present invention, and any device that exhibits the same function and effect is the present invention. It is included in the technical scope of the invention.
Claims (4)
前記シリコン単結晶ウェーハに酸素雰囲気下にて熱処理を行うことにより、前記結晶欠陥内に酸素を注入し、欠陥サイズが25nm以下の結晶欠陥を顕在化して検出可能にする工程と、
前記熱処理後のシリコン単結晶ウェーハの結晶欠陥を検出する工程と
を含み、
前記熱処理時における、前記シリコン単結晶ウェーハの酸素固溶度と初期酸素濃度の比率を、α=酸素固溶度/初期酸素濃度としたとき、αを1以上3以下の範囲になるように前記熱処理における熱処理温度を設定することを特徴とする結晶欠陥の検出方法。 A method for detecting crystal defects present in a silicon single crystal wafer doped with nitrogen and having an initial oxygen concentration of 8 ppma (JEIDA) or less,
Performing a heat treatment in an oxygen atmosphere on the silicon single crystal wafer to inject oxygen into the crystal defects, and to make crystal defects having a defect size of 25 nm or less manifest and detectable;
Detecting a crystal defect of the silicon single crystal wafer after the heat treatment,
When the ratio of the oxygen solid solubility and the initial oxygen concentration of the silicon single crystal wafer during the heat treatment is α = oxygen solid solubility / initial oxygen concentration, α is in the range of 1 or more and 3 or less. A method for detecting a crystal defect, characterized by setting a heat treatment temperature in the heat treatment.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011155910A JP5440564B2 (en) | 2011-07-14 | 2011-07-14 | Method for detecting crystal defects |
| PCT/JP2012/003953 WO2013008391A1 (en) | 2011-07-14 | 2012-06-18 | Method for detecting crystal defects |
| KR1020147000814A KR101858447B1 (en) | 2011-07-14 | 2012-06-18 | Method for detecting crystal defects |
| US14/124,827 US9606030B2 (en) | 2011-07-14 | 2012-06-18 | Method for detecting crystal defects |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011155910A JP5440564B2 (en) | 2011-07-14 | 2011-07-14 | Method for detecting crystal defects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013021276A JP2013021276A (en) | 2013-01-31 |
| JP5440564B2 true JP5440564B2 (en) | 2014-03-12 |
Family
ID=47505702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011155910A Active JP5440564B2 (en) | 2011-07-14 | 2011-07-14 | Method for detecting crystal defects |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9606030B2 (en) |
| JP (1) | JP5440564B2 (en) |
| KR (1) | KR101858447B1 (en) |
| WO (1) | WO2013008391A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6402703B2 (en) * | 2015-11-17 | 2018-10-10 | 信越半導体株式会社 | Defect area determination method |
| CN105486613B (en) * | 2015-12-24 | 2019-07-12 | 上海微谱化工技术服务有限公司 | A kind of method of particle size carbon black in detection nitrile rubber |
| JP6784248B2 (en) * | 2017-09-06 | 2020-11-11 | 信越半導体株式会社 | Evaluation method of point defects |
| CN114280078B (en) * | 2021-12-23 | 2024-04-16 | 宁夏中欣晶圆半导体科技有限公司 | Batch Evaluation Method for BMD in Monocrystalline Silicon |
| JP7666396B2 (en) * | 2022-05-12 | 2025-04-22 | 信越半導体株式会社 | Method for detecting crystal defects in silicon single crystal substrate |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3460434B2 (en) * | 1996-02-22 | 2003-10-27 | 信越半導体株式会社 | Method and apparatus for evaluating oxygen concentration in semiconductor silicon crystal |
| US20020142170A1 (en) * | 1999-07-28 | 2002-10-03 | Sumitomo Metal Industries, Ltd. | Silicon single crystal, silicon wafer, and epitaxial wafer |
| JP3787472B2 (en) | 1999-11-12 | 2006-06-21 | 信越半導体株式会社 | Silicon wafer, method for manufacturing the same, and method for evaluating silicon wafer |
| JP3994665B2 (en) * | 2000-12-28 | 2007-10-24 | 信越半導体株式会社 | Silicon single crystal wafer and method for producing silicon single crystal |
| JP3955441B2 (en) | 2001-02-15 | 2007-08-08 | 信越半導体株式会社 | Evaluation method of silicon wafer and nitrogen-doped annealing wafer |
| JP2005513471A (en) * | 2001-09-17 | 2005-05-12 | バイオクリスタル・リミテッド | Nanocrystal |
| JP3985768B2 (en) * | 2003-10-16 | 2007-10-03 | 株式会社Sumco | Manufacturing method of high resistance silicon wafer |
| JP4805681B2 (en) * | 2006-01-12 | 2011-11-02 | ジルトロニック アクチエンゲゼルシャフト | Epitaxial wafer and method for manufacturing epitaxial wafer |
| FR2899380B1 (en) | 2006-03-31 | 2008-08-29 | Soitec Sa | METHOD FOR REVELATING CRYSTALLINE DEFECTS IN A MASSIVE SUBSTRATE |
| JP4258536B2 (en) * | 2006-08-11 | 2009-04-30 | 独立行政法人産業技術総合研究所 | Method for producing crystallized metal oxide thin film |
| WO2008045327A2 (en) * | 2006-10-06 | 2008-04-17 | Kovio, Inc. | Silicon polymers, methods of polymerizing silicon compounds, and methods of forming thin films from such silicon polymers |
| JP5560546B2 (en) * | 2008-08-28 | 2014-07-30 | 株式会社Sumco | Silicon wafer and manufacturing method thereof |
| JP5163459B2 (en) * | 2008-12-05 | 2013-03-13 | 株式会社Sumco | Silicon single crystal growth method and silicon wafer inspection method |
| KR101389058B1 (en) * | 2009-03-25 | 2014-04-28 | 가부시키가이샤 사무코 | Silicon wafer and method for manufacturing same |
-
2011
- 2011-07-14 JP JP2011155910A patent/JP5440564B2/en active Active
-
2012
- 2012-06-18 US US14/124,827 patent/US9606030B2/en active Active
- 2012-06-18 WO PCT/JP2012/003953 patent/WO2013008391A1/en not_active Ceased
- 2012-06-18 KR KR1020147000814A patent/KR101858447B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20140119399A1 (en) | 2014-05-01 |
| JP2013021276A (en) | 2013-01-31 |
| KR101858447B1 (en) | 2018-05-16 |
| WO2013008391A1 (en) | 2013-01-17 |
| US9606030B2 (en) | 2017-03-28 |
| KR20140061345A (en) | 2014-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3800006B2 (en) | Manufacturing method of silicon single crystal wafer and silicon single crystal wafer | |
| US7964275B2 (en) | Silicon wafer having good intrinsic getterability and method for its production | |
| TWI539041B (en) | Single crystal germanium semiconductor wafer and method of manufacturing same | |
| US6663708B1 (en) | Silicon wafer, and manufacturing method and heat treatment method of the same | |
| JP5998225B2 (en) | Method for indicating the location of crystal related defects | |
| JPWO2000012786A1 (en) | Silicon single crystal wafer manufacturing method and silicon single crystal wafer | |
| JP5440564B2 (en) | Method for detecting crystal defects | |
| JP5439305B2 (en) | Silicon substrate manufacturing method and silicon substrate | |
| EP1406294A1 (en) | SILICON WAFER MANUFACTURING METHOD&comma; SILICON EPITAXIAL WAFER MANUFACTURING METHOD&comma; AND SILICON EPITAXIAL WAFER | |
| CN105917449B (en) | Heat Treatment Method for Monocrystalline Silicon Wafer | |
| US7875116B2 (en) | Silicon single crystal producing method, annealed wafer, and method of producing annealed wafer | |
| JP2010056316A (en) | Silicon wafer, and method of manufacturing the same | |
| JP3080501B2 (en) | Silicon wafer manufacturing method | |
| KR102192287B1 (en) | Heat-treatment method for single-crystal silicon wafer | |
| JP2013048137A (en) | Method for manufacturing silicon wafer | |
| JP2002334886A (en) | Method for evaluating oxygen deposit density in silicon wafer, and the silicon wafer manufactured based on the evaluation method | |
| JP2004119446A (en) | Annealed wafer and method for manufacturing the same | |
| TW201802305A (en) | Silicon wafer | |
| JP5965607B2 (en) | Silicon wafer manufacturing method | |
| JP5560546B2 (en) | Silicon wafer and manufacturing method thereof | |
| JP2004087591A (en) | Method for measuring point defect distribution of silicon monocrystal ingot | |
| JP2004020341A (en) | Method of measuring point defect distribution in silicon single crystal ingot | |
| JP4449842B2 (en) | Measuring method of semiconductor substrate | |
| JP2000277404A (en) | Silicon wafer | |
| JP2007142063A (en) | Silicon single-crystal wafer, method of manufacturing device using the same, and method of manufacturing the silicon single-crystal wafer and evaluation method of the wafer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130619 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130910 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131119 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131202 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5440564 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |